|
| Press Releases |
|
 |
|
| Friday, April 14, 2023 |
|
|
億勝生物與Osteopore簽訂口腔頜面產品在新加坡的獨家代理協議 |
| 億勝生物科技有限公司（「億勝生物」或「集團」，股份代碼：1061.HK）欣然宣佈，集團全資附屬子公司Majeton Pte. Ltd. (「Majeton」)與Osteopore Limited (「Osteopore」)達成合作，就Osteopore的牙科和口腔頜面產品(「產品」)簽訂獨家代理協議。 more info >> |
|
|
Essex and Osteopore Entered into Exclusive Distribution Agreement for Oral Maxillofacial products in Singapore |
| Essex Bio-Technology Ltd. ("Essex" or the "Group", Stock Code: 1061.HK) is pleased to announce that its wholly-owned subsidiary, Majeton Pte. Ltd. ("Majeton"), has entered into an exclusive Distribution Agreement with Osteopore Limited ("Osteopore") to promote and sell Osteopore's dental and oral maxillofacial products ("Products") in Singapore. more info >> |
|
| Tuesday, April 11, 2023 |
|
|
亿胜生物与郡是深圳签订皮耐克®可吸收性敷料在中国大陆的独家代理协议 |
| 亿胜生物科技有限公司（“亿胜生物”或“集团”，股份代码：1061.HK）欣然宣布，集团全资附属子公司珠海亿胜医药有限公司（“亿胜医药”）与日本郡是株式会社（“郡是”）全资子公司郡是医疗器材（深圳）有限公司（“郡是深圳”）达成合作 more info >> |
|
|
億勝生物與郡是深圳簽訂皮耐克®可吸收性敷料在中國大陸的獨家代理協議 |
| 億勝生物科技有限公司（「億勝生物」或「集團」，股份代碼：1061.HK）欣然宣佈，集團全資附屬子公司珠海億勝醫藥有限公司（「億勝醫藥」）與日本郡是株式會社（「郡是」）全資子公司郡是醫療器材（深圳）有限公司（「郡是深圳」）達成合作 more info >> |
|
|
Essex and Gunze Shenzhen Entered into Exclusive Agency Agreement for PELNAC Absorbable Dressing in Mainland China |
| Essex Bio-Technology Ltd. ("Essex" or the "Group", Stock Code: 1061.HK) is pleased to announce that its wholly-owned subsidiary, Essex Medipharma (Zhuhai) Co., Ltd. ("Essex Medipharma"), has entered into an Agency Agreement ("Agency Agreement") with Gunze Medical Devices (Shenzhen) Ltd. more info >> |
|
| Wednesday, March 8, 2023 |
|
|
亿胜生物公布2022年度业绩 |
| 亿胜生物科技有限公司（「亿胜生物」或「集团」；股份代码：1061.HK）今日公布截至2022年12月31日止的年度财务业绩。 more info >> |
|
|
億勝生物公布2022年度業績 |
| 億勝生物科技有限公司（「億勝生物」或「集團」；股份代碼：1061.HK）今日公布截至2022年12月31日止的年度財務業績。 more info >> |
|
|
Essex Bio-Technology Announces 2022 Annual Financial Results |
Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced the annual results for the year ended 31 December 2022.
more info >> |
|
| Wednesday, February 22, 2023 |
|
|
亿胜生物与复宏汉霖签订治疗年龄相关性黄斑变性全球共同开发及独家许可协议之经修订协议 |
| 亿胜生物科技有限公司（「亿胜生物」或「集团」，股票代码：1061.HK）今日宣布，集团全资附属子公司亿胜生物投资有限公司（「亿胜生物投资」）及珠海亿胜生物制药有限公司（「珠海亿胜」）与上海复宏汉霖生物技术股份有限公司（「复宏汉霖」，股票代码：2696.HK）就2020年10月签订的全球共同开发及独家许可协议（「协议」） 签订一份经修订协议（「经修订协议」）。 more info >> |
|
|
億勝生物與復宏漢霖簽訂治療年齡相關性黃斑變性全球共同開發及獨家許可協議之經修訂協議 |
| 億勝生物科技有限公司（「億勝生物」或「集團」，股票代碼：1061.HK）今日宣布，集團全資附屬子公司億勝生物投資有限公司（「億勝生物投資」）及珠海億勝生物製藥有限公司（「珠海億勝」）與上海復宏漢霖生物技術股份有限公司（「復宏漢霖」，股票代碼：2696.HK）就2020年10月簽訂的全球共同開發及獨家許可協議（「協議」） 簽訂一份經修訂協議（「經修訂協議」）。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Ria Money Transfer's New Approval Enables Digital Salary Payments for Malaysia's Migrant Workforce
Jun 13, 2025 13:00: JST
|
|
|
ARE Expands India Leadership, Strengthens Regional Role in Climate, Energy, and Food System Transition
Jun 13, 2025 12:46: JST
|
|
|
Ria Money Transfer's New Approval Enables Digital Salary Payments for Malaysia's Migrant Workforce
Jun 13, 2025 12:00 HKT/SGT
|
|
|
TRENDE Announces Strategic Capital and Business Alliance with Tokyu Land
Jun 13, 2025 13:00 JST
|
|
|
ARE Expands India Leadership, Strengthens Regional Role in Climate, Energy, and Food System Transition
Jun 13, 2025 11:46 HKT/SGT
|
|
|
JBM Healthcare Delivers Strong FY2025 Annual Results, Net Profit Surged 51.2% to HK$197.3 Million
Jun 12, 2025 21:07 HKT/SGT
|
|
|
健倍苗苗二零二五財年全年業績表現亮眼 純利飆升51.2%至1.97億港元
Jun 12, 2025 20:58 HKT/SGT
|
|
|
健倍苗苗二零二五财年全年业绩表现亮眼 纯利飙升51.2%至1.97亿港元
Jun 12, 2025 20:48 HKT/SGT
|
|
|
品質基石的守護者：檢測檢驗行業賦能高質量發展
Jun 12, 2025 18:28 HKT/SGT
|
|
|
质量基石的守护者：检测检验行业赋能高质量发展
Jun 12, 2025 18:19 HKT/SGT
|
|
|
NEFECON(R) and EVER001 Drive Synergistic Progress as Everest Medicines Advances
Jun 12, 2025 17:38: JST
|
|
|
NEFECON(R) and EVER001 Drive Synergistic Progress as Everest Medicines Advances
Jun 12, 2025 16:38 HKT/SGT
|
|
|
耐賦康(R)與EVER001協同發力 雲頂新耀推動腎病治療進入精準管理新階段
Jun 12, 2025 16:31 HKT/SGT
|
|
|
耐赋康(R)与EVER001协同发力 云顶新耀推动肾病治疗进入精准管理新阶段
Jun 12, 2025 16:26 HKT/SGT
|
|
|
10 winners selected at 8th edition of Start-up Express
Jun 12, 2025 12:29 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
